• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性皮炎:现行诊断标准综述及管理更新建议。

Atopic Dermatitis: A Review of Current Diagnostic Criteria and a Proposed Update to Management.

出版信息

J Drugs Dermatol. 2020 Mar 1;19(3):244-248.

PMID:32550689
Abstract

The diagnosis of atopic dermatitis (AD) remains primarily a clinical diagnosis, in which several clinical signs and symptoms including pruritus, the presence and location of skin lesions, and a personal or family history of atopic conditions are used to facilitate a diagnosis. In recent decades, several well-established sets of criteria have been developed to aid diagnosis. With increased awareness of AD and the recent development of systemic immunomodulators to treat the condition, there exists a need to further define and consolidate the current diagnostic criteria while refining our current understanding of the clinical features of AD. We propose a novel, simplified set of criteria that comprises the clinical features generally considered to be essential for a confirmed diagnosis of AD, together with features previously regarded as having less clinical significance. It is essential, however, that any refinements to the diagnostic criteria for AD are made alongside regular updates of treatment guidelines so that these also reflect current developments. In this regard, the current guidelines in the United States are lacking and should be updated. J Drugs Dermatol. 2020;19(3): doi:10.36849/JDD.2020.4737 THIS ARTICLE HAD BEEN MADE AVAILABLE FREE OF CHARGE. PLEASE SCROLL DOWN TO ACCESS THE FULL TEXT OF THIS ARTICLE WITHOUT LOGGING IN. NO PURCHASE NECESSARY. PLEASE CONTACT THE PUBLISHER WITH ANY QUESTIONS.

摘要

特应性皮炎(AD)的诊断主要仍是临床诊断,在诊断过程中会使用多种临床体征和症状,包括瘙痒、皮损的存在和位置,以及特应性疾病的个人或家族史。近几十年来,已经制定了几套公认的标准来辅助诊断。随着对 AD 的认识不断提高,以及最近开发出用于治疗该疾病的全身性免疫调节剂,有必要进一步定义和整合当前的诊断标准,同时深化对 AD 临床特征的认识。我们提出了一套新的简化标准,其中包括通常被认为是确诊 AD 所必需的临床特征,以及以前被认为具有较低临床意义的特征。然而,AD 诊断标准的任何细化都必须与治疗指南的定期更新相结合,以便这些指南也能反映当前的发展。在这方面,美国的现行指南存在不足,需要进行更新。J Drugs Dermatol. 2020;19(3): doi:10.36849/JDD.2020.4737 本文可免费获取。请向下滚动以访问无需登录即可查看本文全文。无需购买。如有任何问题,请与出版商联系。

相似文献

1
Atopic Dermatitis: A Review of Current Diagnostic Criteria and a Proposed Update to Management.特应性皮炎:现行诊断标准综述及管理更新建议。
J Drugs Dermatol. 2020 Mar 1;19(3):244-248.
2
Demographics and Baseline Disease Characteristics of Early Responders to Crisaborole for Atopic Dermatitis.克立硼罗治疗特应性皮炎早期应答者的人口统计学和基线疾病特征
J Drugs Dermatol. 2020 Jun 1;19(6):619-624.
3
Development and validation of new diagnostic criteria for atopic dermatitis in children of China.中国儿童特应性皮炎新诊断标准的制定与验证。
J Eur Acad Dermatol Venereol. 2020 Mar;34(3):542-548. doi: 10.1111/jdv.15979. Epub 2019 Oct 31.
4
Consensus Recommendations on Adjunctive Topical Management of Atopic Dermatitis.特应性皮炎辅助局部治疗的共识建议
J Drugs Dermatol. 2018 Oct 1;17(10):1070-1076.
5
Clinical comparison of human and canine atopic dermatitis using human diagnostic criteria (Japanese Dermatological Association, 2009): proposal of provisional diagnostic criteria for canine atopic dermatitis.使用人类诊断标准(日本皮肤病学会,2009 年)对人类和犬特应性皮炎进行临床比较:犬特应性皮炎临时诊断标准的建议。
J Dermatol. 2011 Aug;38(8):784-90. doi: 10.1111/j.1346-8138.2010.01136.x. Epub 2011 Mar 21.
6
Various diagnostic criteria for atopic dermatitis (AD): A proposal of Reliable Estimation of Atopic Dermatitis in Childhood (REACH) criteria, a novel questionnaire-based diagnostic tool for AD.特应性皮炎(AD)的各种诊断标准:儿童特应性皮炎可靠评估(REACH)标准的提议,一种基于问卷的新型AD诊断工具。
J Dermatol. 2016 Apr;43(4):376-84. doi: 10.1111/1346-8138.13264. Epub 2016 Jan 27.
7
The Heterogeneity of Atopic Dermatitis.特应性皮炎的异质性。
J Drugs Dermatol. 2022 Feb 1;21(2):172-176. doi: 10.36849/JDD.6408.
8
Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis.成人/青少年特应性皮炎的临床特征及中国特应性皮炎诊断标准
Chin Med J (Engl). 2016 Apr 5;129(7):757-62. doi: 10.4103/0366-6999.178960.
9
Clinical Application of the UK Working Party's Criteria for the Diagnosis of Atopic Dermatitis in the Chinese Population by Age Group.英国工作组诊断标准在中国人群中按年龄组对特应性皮炎的临床应用
Chin Med J (Engl). 2016 Dec 5;129(23):2829-2833. doi: 10.4103/0366-6999.194662.
10
Diagnostic criteria for atopic dermatitis: a systematic review.特应性皮炎的诊断标准:一项系统综述
Br J Dermatol. 2008 Apr;158(4):754-65. doi: 10.1111/j.1365-2133.2007.08412.x. Epub 2008 Jan 30.

引用本文的文献

1
Cure for the itch: current clinical standards and therapies in allergic eczema.瘙痒症的治疗:过敏性湿疹的当前临床标准与疗法
Front Allergy. 2025 Apr 3;6:1569292. doi: 10.3389/falgy.2025.1569292. eCollection 2025.
2
Novel drug delivery systems in topical treatment of atopic dermatitis.用于特应性皮炎局部治疗的新型药物递送系统。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 13. doi: 10.1007/s00210-025-04002-4.
3
2023 Consensus Korean Diagnostic Criteria for Atopic Dermatitis.2023年韩国特应性皮炎诊断标准共识
Ann Dermatol. 2025 Feb;37(1):12-21. doi: 10.5021/ad.24.049.
4
Cord Blood 25-Hydroxyvitamin D Level is Correlated with a Risk for Atopic Dermatitis: Systematic Review and Meta-Analysis.脐血25-羟基维生素D水平与特应性皮炎风险相关:系统评价与荟萃分析
Malays J Med Sci. 2024 Aug;31(4):50-62. doi: 10.21315/mjms2024.31.4.4. Epub 2024 Aug 27.
5
Update on the pathogenesis of atopic dermatitis.特应性皮炎发病机制的研究进展。
An Bras Dermatol. 2024 Nov-Dec;99(6):895-915. doi: 10.1016/j.abd.2024.06.001. Epub 2024 Aug 12.
6
Beyond the classic players: Mas-related G protein-coupled receptor member X2 role in pruritus and skin diseases.超越经典参与者:Mas相关G蛋白偶联受体成员X2在瘙痒和皮肤病中的作用
J Eur Acad Dermatol Venereol. 2025 Mar;39(3):476-486. doi: 10.1111/jdv.20249. Epub 2024 Jul 23.
7
MRGPRX2 antagonist GE1111 attenuated DNFB-induced atopic dermatitis in mice by reducing inflammatory cytokines and restoring skin integrity.MRGPRX2 拮抗剂 GE1111 通过减少炎症细胞因子和恢复皮肤完整性来减轻 DNFB 诱导的小鼠特应性皮炎。
Front Immunol. 2024 May 16;15:1406438. doi: 10.3389/fimmu.2024.1406438. eCollection 2024.
8
The Efficacy and Effectiveness of the Biological Treatment of Pruritus in the Course of Atopic Dermatitis.特应性皮炎病程中瘙痒症生物治疗的疗效与效果
J Clin Med. 2024 Mar 18;13(6):1754. doi: 10.3390/jcm13061754.
9
The immunomodulatory activity of against atopic dermatitis: Evidence-based on network pharmacology and molecular simulations.[物质名称]对特应性皮炎的免疫调节活性:基于网络药理学和分子模拟的证据
J Taibah Univ Med Sci. 2023 Nov 4;19(1):164-174. doi: 10.1016/j.jtumed.2023.10.005. eCollection 2024 Feb.
10
Burden of Disease; the Current Status of the Diagnosis and Management of Atopic Dermatitis in China.疾病负担;中国特应性皮炎的诊断与管理现状
J Clin Med. 2023 Aug 18;12(16):5370. doi: 10.3390/jcm12165370.